{"entity":{"id":"086dd371-e33d-5e4b-816a-e0724004a774","name":"Yale Catriona","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001779308","risk":"MED","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"officer","share":null,"subsidiary":{"id":"1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b","name":"Akero Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001744659"}},{"role":"officer","share":null,"subsidiary":{"id":"1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b","name":"Akero Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001744659"}},{"role":"officer","share":null,"subsidiary":{"id":"1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b","name":"Akero Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001744659"}},{"role":"officer","share":null,"subsidiary":{"id":"1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b","name":"Akero Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001744659"}},{"role":"officer","share":null,"subsidiary":{"id":"1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b","name":"Akero Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001744659"}},{"role":"officer","share":null,"subsidiary":{"id":"1f3a658e-849c-5eb6-bb63-c6eefc0a7b8b","name":"Akero Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001744659"}}],"ubo_chain":[]},"risk":{"level":"MED","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (vessels/aircraft/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing."},"source":"corpus"}